On June 7, 2010
Bristol-Myers Comes Clean: Its New Cancer Drug Is Not the “Holy Grail”
Bristol-Myers Squibb (BMY) got some good headlines — and a jump in its stock price — over positive trial results from its new cancer drug, ipilimumab, but most of those stories didn’t mention how modest the drug’s benefit was compared
…
0 Comments